Official UK procurement notice
Hepatitis A, B and Typhoid Vaccines
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)
What is being bought
Published requirement descriptionSupply of hepatitis A, B and typhoid vaccines to NHS Scotland.
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 3 bids received · 3 suppliers appointed
The lotProcurement structure
single lot · value publishedLot #1Supply of hepatitis A, B and typhoid vaccines to NHS ScotlandAwardedRenewalPublished value£2,798,905
Supply of hepatitis A, B and typhoid vaccines to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Logistics: 5%
- price: 95%
Published award criteria (2)
- Logistics: 5
- Price: 95
- Suitability
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015
- Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL or PLGB number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL or PLGB number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technica…
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “Hepatitis A, B and Typhoid Vaccines” is a framework: the contest is a place on its panel, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 20 May 2021, 09:15 BST
- Last source update
- 16 Aug 2021, 16:05 BST
- Award evaluation window
- 21 Jun 2021 – …
- Authority reference
NP42421- FTS notice number
2021/S 000-019971- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02b2fbFind a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
Publisher note: The estimated values referred to in Section II.1.7 and Section V.2.4 cover the thirty-six (36) month contract duration and the twelve (12) month extension period of the framework agreement. (SC Ref:663735)
How it was run
Official notice- Appointment period ends
- 21 Jun 2021, 12:00 BST
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bids opened
- 21 Jun 2021, 12:00 BST
Timeline
21 Jun 2021 → 16 Aug 2021 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown21 Jun 2021, 12:00 BST
- Bids opened21 Jun 2021, 12:00 BST
- Notice published16 Aug 2021, 16:05 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete16 Aug 2021, 16:05 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast1 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Contract 019971-2021-NP42421-1
- Signed
- 21 Jul 2021
- Value
- £2,867,887
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 3bids · 3 electronic · 3 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sheriff Court HouseReview body
Framework contractors & participating bidders
3 commercial parties on the notice- Aventis Pharma Ltd t/a SanofiFramework contractor
- GlaxoSmithKlineFramework contractor
- Merck Sharp & Dohme UK LtdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.